Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

21 Downloads (Pure)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{a9528c4f9f3d46ba94bed228c4612eec,

title = "Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony",

author = "Yeung, \{Stanley M. H.\} and Bakker, \{Stephan J. L.\} and Laverman, \{Gozewijn D.\} and \{De Borst\}, \{Martin H.\}",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s11892-020-01335-7",

language = "English",

volume = "20",

journal = "Current Diabetes Reports",

issn = "1534-4827",

publisher = "Springer",

number = "10",

}

TY - JOUR

T1 - Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony

AU - Yeung, Stanley M. H.

AU - Bakker, Stephan J. L.

AU - Laverman, Gozewijn D.

AU - De Borst, Martin H.

PY - 2020/10/1

Y1 - 2020/10/1

U2 - 10.1007/s11892-020-01335-7

DO - 10.1007/s11892-020-01335-7

M3 - Article

SN - 1534-4827

VL - 20

JO - Current Diabetes Reports

JF - Current Diabetes Reports

IS - 10

M1 - 50

ER -